Sat, Jan 31, 2015, 3:59 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • rojospan rojospan Apr 22, 2013 12:29 AM Flag

    $ 294000x 30000= 8.8 B X5= 44 B market cap

    Just VX 770 potential for Delta 508 homozygous

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Seriously? With healthcare reform, the US government is going to dole out almost $300k per year for a chronic treatment and not a cure? We are still 2-3 years away to find out. So you don't mind locking up your money til then. Oh and by the way, during that time the HCV sales will get nipped away as each one of its competitors launches new HCV drugs. Gilead already submitted its med earlier this month. And unlike CF, when patients with hep C retain levels below 25iu/ml 6 months after cessation of treatment, they are considered cured. The reimbursement for this "cure" is ~$50k. So you really think the reimbursement for a chronic treatment will be 6X?

 
VRTX
110.14-4.00(-3.50%)Jan 30 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.